Por: ABC News Health October 24, 2023
Moderna announced Tuesday it has dosed its first participant in a phase III clinical trial of a .This phase will the safety and efficacy of the combo vaccine compared to flu and COVID vaccines that are administered separately in two groups, one involving 4,000 adults aged 65 and older and another involving 4,000 adults between ages 50 and 64.In , data showed that the vaccine candidate achieved antibody levels similar or greater to the licensed... + full article
Portland Press Herald USA World September 13, 2023
Moderna said a reformulated version of its messenger-RNA-based flu shot met its primary goals in a final-stage trial – a result that could pave the way for the company to seek regulatory approval for the influenza vaccine. In a trial on over 2,400 adults, the reformulated shot... + más
Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Portland Press Herald USA Health March 23, 2023
Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics. Moderna CEO Stephane Bancel testifies during the Senate HELP... + más
Associated Press USA Health March 22, 2023
Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics. Stephane Bancel told the Senate Committee on Health,... + más
MarketWatch USA Business February 28, 2023
The earnings announcement was a sort of rubber-hits-the-road moment for Moderna (ticker: MRNA), as investors, who have been generally anticipating a drop in Covid-19 vaccine sales ever since the jab first was authorized late 2020, for the first time could fully reckon what it... + más
Forbes USA Business November 29, 2022
Getty Images Key Takeaways Moderna became a household name for creating one of the first COVID-19 vaccines, helping to loosen up pandemic restrictions globally. Moderna’s stock went up during the pandemic for apparent reasons as countries were scrambling to purchase mass... + más
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
The Advocate USA Crime October 10, 2022
vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
CBS News USA Health September 22, 2022
Vaccinators around the country are reporting weeks-long delays in shipments of Moderna's updated COVID-19 vaccine boosters. The delays come after the Food and Drug Administration flagged concerns at a facility contracted to fill the Moderna's new shots into vials. The... + más
US clears updated COVID boosters targeting newest variants | ABC News
US clears updated COVID boosters targeting newest variants | 10 WBNS
About iurex | Privacy Policy | Disclaimer |